ZNF41
protein-codingzinc finger protein 41, the group of Zinc fingers C2H2-type
Gene summary
This gene encodes a protein that contains KRAB-A and KRAB-B domains multiple zinc finger DNA binding motifs and finger linking regions characteristic of the Kruppel family. An initial study suggested that this gene may be associated with X-linked cognitive disability, but a later study has called this finding into question (PMID:23871722).[provided by RefSeq, Apr 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~38.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: ClinGen
The association between ZNF41 and X-linked non-syndromic intellectual disability was first suggested in 2013 (Shoichet et al., PMID: 14628291). This study reported three unrelated families with intellectual disability and variants involving ZNF41. One female was found to have a de novo balanced X;7 translocation disrupting ZNF41. This translocation was not counted as evidence because the impact of the breakpoints on neighboring genes cannot be ruled out. The second family had two affected brothers with a maternally inherited missense variant in ZNF41. The third family included an affected male proband and an affected sister with borderline ID with a maternally inherited deep intronic variant in ZNF41 that resulted in loss of specific ZNF41 splice variants. The two ZNF41 sequence variants were found to have high population frequencies in gnomAD (v2.1.1) and were not scored as evidence. No additional studies have been reported since then with causative ZNF41 variants in affected individuals. In summary, there is no valid genetic evidence to support an association between ZNF41 and X-linked nonsyndromic intellectual disability, so this gene-disease association is disputed. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 09/02/2020 (SOP Version 7).
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The evidence of variants as being related to disease causation has been questioned due to subsequent population-based studies
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZNF41 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001324144.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 13 | 2 | 19 | ||
| missense | 92 | 13 | 6 | 111 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 0 | 105 | 26 | 8 | 139 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001311073.1 | 4 | MANE Select | |
| Ensembl | ENSP00000508254.1 | 4 | MANE Select | |
| RefSeq | NP_001311068.1 | 2 | Standard | |
| RefSeq | NP_001311069.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
Biological Process
- regulation of transcription by RNA polymerase II
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- protein binding
- metal ion binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000377065
- Coding exons
- 4
- Length
- 37068
- Individuals with no LoFs
- 125727
- Homozygous LoFs
- 4
- Heterozygous LoFs
- 12
- Defined
- 125743
- p
- 0.0000636
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.30 | 229 | 292 | 0.785 | 0.0000213 | 5206 |
| Missense (PolyPhen) | 69 | 104.7 | 0.65902 | 1946 | ||
| Synonymous | 0.383 | 100 | 105 | 0.952 | 0.00000812 | 1361 |
| Loss of Function | 2.78 | 6 | 19.1 | 0.313 | 0.00000128 | 413 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00030 | 0.00025 | rare |
| Latino/Admixed American | 0.000036 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000072 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00011 | 0.000079 | rare |
| South Asian | 0.000052 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation.;
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- LoFtool
- 0.831
- RVIS EVS
- 0.73
- RVIS percentile EVS
- 86.27
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.316
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |